CD8A and hepatocellular carcinoma: It has been reported that increased intra-tumoral FABP5 contributes to CD8+ T-cell infiltration and is linked to overall and recurrence-free survival, indicating that FABP5 could be an immunometabolic marker in hepatocellular carcinoma (57).